About: Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 31 July 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2007 (uk) article scientifique publié en 2007 (fr) scientific article published on 31 July 2007 (en) artículu científicu espublizáu en xunetu de 2007 (ast) գիտական հոդված հրատարակված 2007 թվականի հուլիսի 31-ին (hy)
publication date	wds:Q80709857-13FB17B6-8A8D-46F0-8C2E-E14B1310F6CA
publication date	2007-07-31 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q80709857-0A32F25D-5058-4390-9B8C-319E523BE9D5
language of work or name	English
author name string	wds:Q80709857-AED5CBE2-89EC-4E20-97EC-89331010F8B2 wds:Q80709857-CA9C077B-4202-4439-A3B5-67B6B0D9D3E9 wds:Q80709857-EF71B9FE-D2F9-4677-BFF3-6B3ACABC0E6C
author name string	J Oliver Dolly Jianghui Meng Gary Lawrence
rdfs:label	Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (en) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (nl)
skos:prefLabel	Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (en) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (nl)
name	Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (en) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (nl)
author	wds:Q80709857-8962FB44-B686-471C-A66D-AB6A6E01D7BB
author	Jiafu Wang
title	wds:Q80709857-4E536821-0F6B-4D78-9C8C-6AE7177EEBEB
title	Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential (en)
page(s)	wds:Q80709857-C234CC18-38FB-4DB3-9CF6-E614DD7A59D6
page(s)	2864-2874
instance of	wds:Q80709857-0D2C4A33-3D74-4866-BA5B-480A9A7C7363
instance of	scholarly article
main subject	wds:Q80709857-2AFFC0CB-92FF-4E8E-9E3C-E8E5199CD95E
main subject	exocytosis
PubMed ID	wds:Q80709857-D0B8C816-9548-43BF-ABA3-72FC15DB6B0C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17666428
PubMed ID	17666428
published in	wds:Q80709857-E461BC3D-C6B3-480F-8500-AE6E8812F046
published in	Journal of Cell Science
issue	wds:Q80709857-646619F5-77ED-4D2A-8763-7B2378E79D12
volume	wds:Q80709857-59E645C3-5162-425C-BD54-114959310B11
issue	Pt 16
volume	120
DOI	wds:Q80709857-41875E45-0594-45E6-A471-14B8139B09E5
DOI	http://dx.doi.org/10.1242/JCS.012211
DOI	10.1242/JCS.012211
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80709857
is cites work of	Calcitonin Gene-Related Peptide-Mediated Enhancement of Purinergic Neuron/Glia Communication by the Algogenic Factor Bradykinin in Mouse Trigeminal Ganglia from Wild-Type and R192Q Cav2.1 Knock-In Mice: Implications for Basic Mechanisms of Migraine P SNAP-23 and VAMP-3 contribute to the release of IL-6 and TNFα from a human synovial sarcoma cell line Calcitonin gene-related peptide: physiology and pathophysiology Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial An update on botulinum toxin A injections of trigger points for myofascial pain Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy Neuroarchitecture of aminergic systems in the larval ventral ganglion of Drosophila melanogaster Botulinum toxin therapy for osteoarticular pain: an evidence-based review Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA. Nociceptive signals induce trafficking of TRPA1 to the plasma membrane TNFα induces co-trafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1/syntaxin1/SNAP-25 mediated fusion Therapeutic use of botulinum toxin in migraine: mechanisms of action Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior Botulinum toxin type A induces changes in the chemical coding of substance P-immunoreactive dorsal root ganglia sensory neurons supplying the porcine urinary bladder OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data The anti-inflammatory effects of acupuncture and their relevance to allergic rhinitis: a narrative review and proposed model Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment Insights into the mechanism of onabotulinumtoxinA in chronic migraine Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China Protective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction? Intravesical treatments of bladder pain syndrome/interstitial cystitis SNAP25 Ameliorates Sensory Deficit in Rats with Spinal Cord Transection Current status and future directions of botulinum neurotoxins for targeting pain processing Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins Structural and Functional Interactions between Transient Receptor Potential Vanilloid Subfamily 1 and Botulinum Neurotoxin Serotype A. Selective cleavage of SNAREs in sensory neurons unveils protein complexes mediating peptide exocytosis triggered by different stimuli Botulinum neurotoxin in the treatment of headache disorders Neuronal entry and high neurotoxicity of botulinum neurotoxin A require its N-terminal binding sub-domain Treatment of chronic migraine headache with onabotulinumtoxinA. Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model Botulinum neurotoxin for pain management: insights from animal models Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors. Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection. Acid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: a potential mechanism of inflammatory pain Botulinum Toxin for the Treatment of Neuropathic Pain Neurogenic inflammation and its role in migraine. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain Emerging opportunities for serotypes of botulinum neurotoxins Transient receptor potentials (TRPs) and anaphylaxis Botulinum toxin type a therapy in migraine: preclinical and clinical trials Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle Botulinum neurotoxins in the treatment of refractory pain Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? Cutaneous neuroma physiology and its relationship to chronic pain

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software